Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Female Contraceptives
Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual’s life. The absence of sexual and reproductive healthcare programs for adolescents can result in unwanted pregnancies and unsafe abortions.
Technavio’s analysts forecast the global female contraceptive market to grow at a CAGR of 3.48% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global female contraceptives market for 2016-2020. To calculate the market size, the report considers the revenue generated from the overall retail sales of female contraceptive products globally.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Female Contraceptives 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Allergan
• Merck Millipore
• Pfizer
• Teva Pharmaceuticals
Other prominent vendors
• Afaxys
• Agile Therapeutics
• Ansell
• Bayer Pharma
• Caya
• Ferring Pharmaceuticals
• Female Health
• Fuji Latex
• HLL Lifecare
• Janssen Pharmaceuticals
• Lipocine
• Lupin Pharmaceuticals
• Mayer Laboratories
• Okamoto Industries
• Reckitt Benckiser
• Syzygy Healthcare
• V-Care Pharma
Market driver
• Growing importance of family planning
• For a full, detailed list, view our report
Market challenge
• High cost and inaccessibility of health services
• For a full, detailed list, view our report
Market trend
• Growing cases of sexually transmitted diseases (STDs)
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual’s life. The absence of sexual and reproductive healthcare programs for adolescents can result in unwanted pregnancies and unsafe abortions.
Technavio’s analysts forecast the global female contraceptive market to grow at a CAGR of 3.48% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global female contraceptives market for 2016-2020. To calculate the market size, the report considers the revenue generated from the overall retail sales of female contraceptive products globally.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Female Contraceptives 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Allergan
• Merck Millipore
• Pfizer
• Teva Pharmaceuticals
Other prominent vendors
• Afaxys
• Agile Therapeutics
• Ansell
• Bayer Pharma
• Caya
• Ferring Pharmaceuticals
• Female Health
• Fuji Latex
• HLL Lifecare
• Janssen Pharmaceuticals
• Lipocine
• Lupin Pharmaceuticals
• Mayer Laboratories
• Okamoto Industries
• Reckitt Benckiser
• Syzygy Healthcare
• V-Care Pharma
Market driver
• Growing importance of family planning
• For a full, detailed list, view our report
Market challenge
• High cost and inaccessibility of health services
• For a full, detailed list, view our report
Market trend
• Growing cases of sexually transmitted diseases (STDs)
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
